Showing results (731-740 of 896) with videos related to

Sort By:
Pageof 90
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2025
Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinomaB I Rini, L Albiges, X Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2012
Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patientsArjan W Griffioen, Laurie A Mans, Annemarie M A de Graaf, et al.
European Urology|May 17, 2020
Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 PandemicChristopher J D Wallis, Giacomo Novara, Laura Marandino, et al.
The Journal of Urology|November 25, 2015
Clinical Relevance of Incidental Prostatic Lesions on FDG-Positron Emission Tomography/Computerized Tomography-Should Patients Receive Further Evaluation?Daan J Reesink, Elisabeth E Fransen van de Putte, Erik Vegt, et al.
European Urology|October 17, 2022
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines PanelUmberto Capitanio, Jens Bedke, Laurence Albiges, et al.
BMJ Open|June 14, 2019
Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing NEphron Sparing Treatment (NEST) for small renal massesJoana B Neves, David Cullen, Lee Grant, et al.
BMC Medicine|October 4, 2019
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohortTobias Klatte, Kevin M Gallagher, Luca Afferi, et al.
World Journal of Urology|July 18, 2015
Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatinElisabeth E Fransen van de Putte, Laura S Mertens, Richard P Meijer, et al.
European Urology|February 4, 2025
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell CarcinomaJens Bedke, Yasmin Abu Ghanem, Laurence Albiges, et al.
European Urology Oncology|December 12, 2024
Is Frequent Imaging Necessary? Impact of Computed Tomography During Follow-up After Surgical Treatment for Nonmetastatic Renal Cell Carcinoma: A Systematic ReviewLuna van den Brink, Marlin A A Reijerink, Michael M E L Henderickx, et al.
Pageof 90